Coronavirus

Covid response the right medicine for Dawaai growth

Karachi-based Dawaai, the on-line pharmaceuticals startup in Pakistan closed its series A funding at the end of March. It is on the way to turning a profit by the end of the year as the pharmaceuticals and medical supplies aggregator rushes to meet demand generated by the Covid-19 pandemic.

While the onset of Covid-19 has resulted in most people working from home, the founder of Pakistan’s first medical e-commerce site is busier than ever. Since mid-March, cities across the country have been under a lockdown enforced by army troops. Only services deemed “essential” - including medical deliveries - are permitted to continue unaffected. The pandemic has proved a boon for Dawaai’s business.

¬ Haymarket Media Limited. All rights reserved.

Sign in to read on!

Registered users get 2 free articles in 30 days.

Subscribers have full unlimited access to FinanceAsia.

Not signed up? New users get 2 free articles per month, plus a 7-day unlimited free trial.

Questions?
See here for more information on licences and prices, or contact [email protected].

Share our publication on social media
Share our publication on social media